Stock-Based Compensation (Stock-Settled Stock Appreciation Rights Activity) (Details) (Stock Settled Stock Appreciation Rights SARS [Member], USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Stock Settled Stock Appreciation Rights SARS [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Rights, Outstanding at beginning of period	374
Number of Rights, Exercised	(150)
Number of Rights, Granted	146	108	187
Number of Rights, Forfeited	(12)
Number of Rights, Outstanding at end of period	358	374
Number of Rights, Exercisable and vested at end of period	84
Number of Rights, Vested and expected to vest at end of period	320
Weighted Average Exercise Price, Outstanding at beginning of period	$ 66.42
Weighted Average Exercise Price, Exercised	$ 63.68
Weighted Average Exercise Price, Granted	$ 89.16
Weighted Average Exercise Price, Forfeited	$ 68.32
Weighted Average Exercise Price, Outstanding at end of period	$ 76.75	$ 66.42
Weighted Average Exercise Price, Exercisable and vested at end of period	$ 64.63
Weighted Average Exercise Price, Vested and expected to vest at end of period	$ 76.44
Weighted Average Remaining Contractual Life, Outstanding at end of period	3 years 6 months 26 days
Weighted Average Remaining Contractual Life, Exercisable and vested at end of period	2 years 2 months 23 days
Weighted Average Remaining Contractual Life, Vested and expected to vest at end of period	3 years 6 months 11 days
Aggregate Intrinsic Value, Outstanding at end of period	$ 6,594
Aggregate Intrinsic Value, Exercisable and vested at end of period	2,573
Aggregate Intrinsic Value, Vested and expected to vest at end of period	$ 5,991